Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...

Western genomes won’t cut it. Experts from IIT Madras and Karkinos Healthcare, leading the Bharat Cancer Genome Atlas (BCGA), ...

The American Association for Cancer Research Annual Meeting 2025 will be held from April 25-30 in Chicago, Illinois, ...

7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer Treatment ...

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.

The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

Ongoing proof-of-concept (PoC) clinical trial in pain associated with pancreatic cancer with topline data on track for 1H 2025Continued solid ...

The foundation hopes to put the funds toward two clinical programs in blood cancers and one preclinical project in solid tumors.

Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...